Zyversa Therapeutics Inc
(ZVSA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 20,752 | 2,044 | 2,145 | 1,287 | 2,270 |
| Operating Income | -20,752 | -2,044 | -2,145 | -1,287 | -2,270 |
| Interest Expense | 131 | 130 | 120 | 138 | 132 |
| Other Income | 226 | -37 | 7 | 0 | 0 |
| Pre-tax Income | -20,657 | -2,211 | -2,257 | -1,425 | -2,401 |
| Income Tax | -852 | N/A | N/A | -3 | N/A |
| Net Income Continuous | -19,806 | -2,211 | -2,257 | -1,422 | -2,401 |
| Net Income | $-19,806 | $-2,211 | $-2,257 | $-1,422 | $-2,401 |
| EPS Basic Total Ops | -2.56 | -0.46 | -0.73 | 1.79 | -2.43 |
| EPS Basic Continuous Ops | -2.56 | -0.46 | -0.73 | 1.79 | -2.43 |
| EPS Diluted Total Ops | -2.56 | -0.46 | -0.73 | 1.79 | -2.43 |
| EPS Diluted Continuous Ops | -2.56 | -0.46 | -0.73 | 1.79 | -2.43 |
| EPS Diluted Before Non-Recurring Items | -0.15 | -0.46 | -0.73 | N/A | -2.43 |
| EBITDA(a) | $-20,752 | $-2,044 | $-2,145 | $-1,287 | $-2,268 |